Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients

NCT04115007 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Hormone Sensitive Prostate Cancer

Interventions

RADIATION: Stereotactic Body Radiotherapy (SBRT) + Standard of care
DRUG: Standard of care

Sponsor

UNICANCER